[
    [
        {
            "time": "",
            "original_text": "【CRO?深度系列二】内资药企需求高增长，助力CRO产业第三波浪潮 | 【光大医药】",
            "features": {
                "keywords": [
                    "CRO",
                    "内资药企",
                    "高增长",
                    "第三波浪潮",
                    "光大医药"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO产业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【CRO?深度系列二】内资药企需求高增长，助力CRO产业第三波浪潮 | 【光大医药】",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]